ScholarIQanswers from OpenAlex

EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance

PaperCitations, authors & open-access status

EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance is a paper indexed in ScholarIQ from OpenAlex.

How many citations does EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance have?

ScholarIQcitation count

EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance has 85 citations in the OpenAlex counts ScholarIQ stores.

When was EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance published?

ScholarIQyear

EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance has 2019 year in the ScholarIQ index.

What is the open-access status of EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance?

ScholarIQoa status

EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance has bronze oa status in the ScholarIQ index.

What is the DOI of EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance?

ScholarIQdoi

The DOI for EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance is on the source record.

What is the PMID of EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance?

ScholarIQpmid

The PMID for EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance is on the source record.

What is the OpenAlex record for EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance?

ScholarIQopenalex

The OpenAlex for EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial